Uk Mhra Approves Gsk & Vir Biotechnologys Xevudy To Treat Covid-19

Uk Mhra Approves Gsk & Vir Biotechnologys Xevudy To Treat Covid-19

The Uk Medicines And Healthcare Products Regulatory Agency (Mhra) Has Approved Another Covid-19 Treatment Xevudy (Sotrovimab) After It Was Found To Be Safe And Effective At Reducing The Risk Of Hospitalisation And Death In People With Mild To Moderate Covid-19 Infection Who Are At An Increased Risk Of Developing Severe Disease.This Approval Follows A Rigorous Review Of Its Safety, Quality And Effectiveness By The Uk Regulator And The Government

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!